Companies
Chugai Expands Roche Cancer Test in Japan With New Approval
Roche subsidiary Chugai Pharmaceutical has received Japanese approval for its FoundationOne CDx test as companion diagnostics for the drug Tovorafenib, broadening its use to nine cancer types.
Karman Space & Defense Touts Growth, Capacity Expansion and Cash Goals
The defense contractor reported 25% organic growth, nearly 30% EBITDA margins, and outlined a Salt Lake City facility that will quadruple launch capacity as it pursues 80% cash conversion by 2027.
Graphic Packaging Raises Free Cash Flow Guidance, Eyes Mid-Teen Margins
CEO Robbert Rietbroek targets LTM free cash flow of $600M–$700M and long-term EBITDA margins in the mid-teens as pricing actions and cost cuts offset inflation headwinds.
Novavax Partnerships Push Cash Runway Into the 2030s
Novavax says deals with Sanofi and Pfizer extend its cash runway into the 2030s, as the company pivots from a COVID-only vaccine maker to a broader platform business.
Resideo's Growth Plan Survives OEM Security Pullback, CFO Says
Resideo (REZI) outlined a strategy to offset shrinking OEM security revenue through margin gains and mid-single-digit growth, even as it exits a low-margin contract running through 2028.
Ironwood's LINZESS Rebound Fuels Turnaround as Debt Vanishes
Ironwood Pharmaceuticals raised full-year LINZESS guidance above $1 billion and paid off $200 million in debt, as the company posted a strong earnings recovery at a Wells Fargo conference.
Anthropic delays IPO amid AI competition, safety concerns
Anthropic is evaluating a new AI model amid OpenAI’s rapid revenue growth and investor scrutiny over profitability and safety risks.
Oracle's Data Center Debt Under Pressure Amid Project Concerns
Oracle's $18 billion loan for Project Jupiter data center faces challenges as debt distribution stalls and power infrastructure issues arise.
AI reshapes wealth advisory: banks face a competence shift
Bank advisors must adapt as customers use AI tools to fact-check recommendations and demand higher-value guidance.
Datasea signs AI agent service contracts with five Chinese customers
Datasea Intelligent Technology announced AI agent digital marketing agreements with five firms, forecasting monthly fees of $0.45‑$1.49 million per client and a total service value of about $1.10 million to date.
U.S. new home listings surge 2.6% in August, highest since 2022
Redfin data shows a rebound in inventory, though prices and mortgage rates remain elevated.
FINMA warns of AI-fuelled cyberattacks hitting Swiss financial sector
Switzerland's financial regulator says attacks on its sector surged 33%, with bad actors increasingly using generative-AI tools from firms such as OpenAI and Anthropic.
Lombard Odier: Young donors demand measurable impact and innovation
A survey of 260 high-net-worth individuals across four markets reveals generational divides in philanthropic priorities and a surging demand for banks to integrate giving into wealth strategies.
GSK Reports Strong Trial Data for Lung Cancer Drug Jideytro
GSK's ARROS-1 trial showed a 94% response rate and 100% intracranial response in treatment-naïve ROS1-positive lung cancer patients, boosting outlook for a supplemental FDA filing this year.
Hardide Lands $1.9M Order for Energy Sector Components
Hardide secured a $1.9 million production order from a North American energy customer for second-generation tungsten carbide-coated components, to be delivered starting October 2026.
Arcus Biosciences sees $4B+ frontline opportunity for HIF-2α inhibitor casdatifan
Arcus Biosciences presented late-line and combination clinical data for casdatifan at Cantor's healthcare conference, projecting up to $6 billion in combined commercial opportunity across metastatic kidney cancer.
Incyte outlines $3B–$4B revenue floor, pipeline-driven growth through 2035
CEO Bill Meury said Incyte aims to reach a $3 billion–$4 billion core-business revenue floor within 12–18 months, with five key assets representing roughly 80% of post-Jakafi recovery.
Power Corporation highlights active ownership at Scotiabank summit
Power Corporation of Canada discusses its active ownership strategy and financial targets at the Scotiabank 27th Annual Financials Summit, with a focus on sustainable growth and AI investments.
IFF says turnaround gains traction as leverage falls to 2.5x
CEO Erik Fyrwald highlighted progress on the three‑business model, a $3.8 bn Food Ingredients divestiture and a $2.5 bn share buyback while noting leverage has dropped to 2.5‑times.
Aflac CFO Highlights 2026 Growth, AI and Japan Repositioning
Aflac’s CFO Max Brodén discussed capital allocation, operational efficiency gains from AI, and Japan’s evolving insurance market at KBW Insurance Conference 2026.
Eco Buildings nears completion of first Albania apartment block
UK-listed construction firm hits key milestone on €13.2 million development with Balfin Group in Tirane, expects final contracts by year-end.
AI Risk to Enter 60–80% of Insurance Underwriting by 2028, ScienceSoft Says
ScienceSoft projects AI risk considerations will become standard in E&O, D&O, employment practices and cyber insurance underwriting within two years.
Articulate and Thinkific Partner on One-Click Content Integration
Articulate and Thinkific Labs Inc. have launched a product integration that allows joint customers to publish training content between platforms with one click, eliminating manual exports, repackaging, and re-uploads.
Specialised Therapeutics expands Incyte partnership to commercialize ruxolitinib cream in Australia
Specialised Therapeutics, based in Singapore, will handle regulatory, medical, marketing and distribution duties for Incyte's ruxolitinib cream, Opzelura, across Australia.